David Johnson
David Johnson
Editor-in-Chief, Associate Professor, Duquesne University, USA
Biography
Dr. Johnson is currently an Associate Professor of Pharmacology and Toxicology and the Division Head of Pharmaceutical Sciences of the Mylan School of Pharmacy and Graduate School of Pharmaceutical Sciences at Duquesne University, Pittsburgh, Pennsylvania. Dr. Johnson received his Ph.D. from the Massachusetts College of Pharmacy and Allied Health Sciences in 1990 majoring in Pharmacology with a minor in Neuroscience. Following the award of his degree, Dr. Johnson was a post-doctoral fellow in the laboratories of Dr. Bernard Lown at the Harvard School of Public Health and Dr. Richard J. Wurtman at Interneuron Pharmaceuticals. His primary scholarly interests include cholinergic function in learning, memory and attention. Dr. Johnson has authored over 50 publications in various areas of Pharmacology, several book chapters and two patents. Most recently, Dr. Johnson directed a clinical trial of the cognitive enhancing effects of an acetylcholine precursor and excitatory neuromodulators.
Research Interest
His scholarly interests include the neuroscience of memory and novel therapies for the treatment of Parkinson’s disease, Vascular Pharmacology, Biology of Aging, Eating Disorders.